EASL Studio Podcast: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within

Antimicrobial resistance (AMR) is growing problem that greatly impacts treatment outcome. In this episode the faculty discuss:The impact of prescribing antibiotics as primary and secondary prophylaxis on AMR ratesWhat can be done globally to reduce AMR ratesFacultyProf. Debbie Shawcross (Moderator)Prof. Jonel Trebicka (Moderator)Prof. Jasmohan Bajaj (Faculty)Dr Lindsey Edwards (Faculty)Dr Benedikt Huttner (Faculty, WHO representative)All EASL Studio Podcasts are available on EASL Campus.

Episode metadata supplied by the publisher feed · Published Nov 24, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

EASL Studio Podcast: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within

0:00 37:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of EASL Podcasts?

This episode is 37 minutes long.

When was this EASL Podcasts episode published?

This episode was published on November 24, 2022.

Can I download this EASL Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!